Clinical Trials

Knee Osteoarthritis (KOA)

Liver Cancer (HCC)

Investors


OTCQB: CBMG - Robust product pipelines addressing multiple large market opportunities

Management


CBMG has a research, development and manufacturing team with more than 30 years of relevant experience in China, England, and the USA. CBMG is a leading cell therapy...

 

Recent Press

CBMG in the Press

Currently, patients suffering from osteoarthritis in China number approximately 40 million people

  •  
  •  
  •